Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy

Endothelial progenitor cells (EPCs) contribute to endothelial regeneration and thereby protect against cardiovascular disease (CVD). Patients with manifest CVD have reduced EPC levels, but it is not clear if this also occurs in subjects at high CVD risk without manifest atherosclerotic disease. Ther...

Full description

Saved in:

Bibliographic Details
Published in:	European heart journal Vol. 29; no. 22; p. 2808
Main Authors:	Westerweel, Peter E, Visseren, Frank L J, Hajer, Gideon R, Olijhoek, Jobien K, Hoefer, Imo E, de Bree, Petra, Rafii, Shahin, Doevendans, Pieter A, Verhaar, Marianne C
Format:	Journal Article
Language:	English
Published:	England 01.11.2008
Subjects:	Anticholesteremic Agents - pharmacology Azetidines - pharmacology Cross-Over Studies Drug Therapy, Combination Endothelial Cells - cytology Endothelium, Vascular - drug effects Ezetimibe Humans Male Metabolic Syndrome - complications Metabolic Syndrome - drug therapy Middle Aged Obesity - complications Postprandial Period - physiology Simvastatin - pharmacology Stem Cells - drug effects Stem Cells - physiology
ISSN:	1522-9645, 1522-9645
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!